SCHEMBL28030943

SCHEMBL28030943

Cc1nc2cccc(CN)c2c(=O)n1C1CCC(C(=O)C=O)NC1

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 2/20 0.38
CRBN Q96SW2 2/20 0.38
TNF P01375 1/20 0.38
IL1B P01584 1/20 0.38
IKZF3 Q9UKT9 1/20 0.38
GAA P10253 1/20 0.35
ALOX15 P16050 1/20 0.35
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27936623 0.88 DDB1 (0.51) DDB1CRBNTNFIL1BIKZF3
SCHEMBL28030946 0.88 DDB1 (0.39) DDB1CRBNTNFIL1BIKZF3
SCHEMBL25346369 0.87 TNF (0.34) DDB1CRBNTNFIL1BIKZF3
SCHEMBL25433270 0.86 LMNA (0.33) DDB1CRBNTNFIL1BIKZF3
SCHEMBL28822138 0.86 HRH3 (0.39) DDB1CRBNTNFIL1BIKZF3
SCHEMBL25429548 0.83 HTR1A (0.34) DDB1CRBNTNFIL1BIKZF3
SCHEMBL25430058 0.83 HTR1A (0.34) DDB1CRBNTNFIL1BIKZF3
SCHEMBL27780651 0.83 HTT (0.37) DDB1CRBNTNFIL1BIKZF3
SCHEMBL28030321 0.79 PIK3CD (0.36) DDB1CRBNTNFIL1BIKZF3
SCHEMBL25345320 0.78 TNF (0.35) DDB1CRBNTNFIL1BIKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105017212-A 5-substituted quinazolinone derivatives using as antineoplastic agent CELGENE CORP 2015-11-04 CN disclosed
CN-104910133-A 5-SUBSTITUTED QUINAZOLINONE DERIVATIVES AS ANTITUMOR AGENTS CELGENE CORP 2015-09-16 CN disclosed
CN-104876908-A 5-substituted quinazolinone derivatives as anti-cancer agents CELGENE CORP 2015-09-02 CN disclosed